Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 2, 2002, Pages 135-143

  Knoll, U ^a   Strauhs, P ^a   Schusser, G ^a   Ungemach, F R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; DRUG METABOLITE; MESALAZINE; OLSALAZINE; PRODRUG; WATER;

ACETYLATION; ANIMAL EXPERIMENT; ARTICLE; BACTERIUM; BLOOD ANALYSIS; BLOOD CHEMISTRY; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG METABOLISM; DRUG TOLERANCE; DRUG TRANSFORMATION; FECES; FECES ANALYSIS; FEMALE; HEMATOLOGICAL PARAMETERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; TIME;

ADMINISTRATION, ORAL; AMINOSALICYLIC ACIDS; ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FECES; FEMALE; HORSE DISEASES; HORSES; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; MALE; PRODRUGS;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS;

EID: 0036093949     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00395.x     Document Type: Article

References (26)

1. Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid
2. Bioavailability and bioequivalence of veterinary drug dosage forms
3. Pharmacokinetics: Disposition and fate of drugs in the body
4. Pharmacokinetics of 5-aminosalicylic acid in man following administration of intravenous bolus and per os slow-release formulation
5. Comparative bioavailability of 5-aminosalicylic acid from a controlled release preparation and an azo-bond preparation
6. Clinical pharmacokinetics of sulphasalazine
7. High-performance liquid chromatographic assay for the determination of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid concentrations in endoscopic intestinal biopsy in humans
8. Therapeutische maβnahmen bei typhlokolitis
9. Pharmakotherapie im gastrointestin-altrakt
10. Mediatoren der entzündung und allergie
11. Azodisalicylate (azodisal sodium) causes intestinal secretion
12. Disposition of disodium azodisali cylate in healthy subjects
13. Studies on the acetylating capacity of human colonic epithelial cells for 5-ASA
14. Pharmacokinetic study of olsalazine in horses following oral administration of olsalazine sodium
15. Estimation of variance for mean half-lives
16. Keratoconjunctivitis sicca associated with sulfonamide therapy in dogs
17. Renal clearance and fractional excretion of electrolytes over a 24-hour period in horses
18. Krankheiten der verdauungsorgane
19. The anti-oxidant properties of 5-aminosalicylic acid
20. Verdauung
21. The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food
22. Relative bioavailability of olsalazine from tablets and capsules: A drug targeted for local effect in the colon
23. Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulpha-pyridine (sulphasalazine)
24. Chapter 18: Diarrhea
25. Sulfonamides